Pinnacle Health Rehab Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1201 N Raul Longoria Rd, Suite P, San Juan, TX 78589 Phone: 210-520-1723 Fax: 210-520-1724 |
Mr. Michael Anthony Martinez, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1201 N Raul Longoria Rd, Suite P, San Juan, TX 78589 Phone: 210-870-9430 |
Elizabeth Dalton, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1201 N Raul Longoria Rd, Suite P, San Juan, TX 78589 Phone: 210-520-1723 Fax: 210-520-1724 |
Paradigm Wellness And Rehabilitation L.l.c. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 909 W Fm 495, Suite 1, San Juan, TX 78589 Phone: 956-475-3662 Fax: 956-475-3663 |
Abilicare Therapy, Pllc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1201 N Raul Longoria Rd, Suite P, San Juan, TX 78589 Phone: 210-520-1723 Fax: 210-520-1724 |
Shelly L Duffey, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1110 S Stewart Rd Ste D, San Juan, TX 78589 Phone: 956-283-7555 Fax: 956-283-7557 |
News Archive
Researchers using a novel sensitized ENU (N-ethyl-N-nitrosourea, a carcinogen-induced animal tumor model established to grow malignant and benign tumors) mutagenesis (induction of mutation) screen in laboratory mice have developed a promising approach to genetic screening that can increase the likelihood of identifying dominant suppressors of thrombosis.
Lexicon Pharmaceuticals, Inc.'s telotristat etiprate, the first oral therapy in development for the treatment of carcinoid syndrome (CS), was associated with patient-reported improvements in social and physical function and emotional well-being according to new exit interview data from the Phase 3 TELESTAR study presented at the 2015 Neuroendocrine Tumor Society Annual Symposium in Austin, Texas.
Soldiers exposed to the deafening din of battle have little defense against hearing loss, and are often reluctant to wear protective gear like ear plugs that could make them less able to react to danger.
McKesson Corporation today reported that revenues for the first quarter ended June 30, 2010 were $27.5 billion compared to $26.7 billion a year ago. First-quarter earnings per diluted share was $1.10 compared to $1.06 per diluted share a year ago.
› Verified 8 days ago